发明名称 |
Reprogramming cells |
摘要 |
The present invention provides for methods, compositions, and kits for producing an induced pluripotent stem cell from a non-pluripotent mammalian cell using a 3′-phosphoinositide-dependent kinase-1 (PDK1) activator or a compound that promotes glycolytic metabolism as well as other small molecules. |
申请公布号 |
US9315779(B2) |
申请公布日期 |
2016.04.19 |
申请号 |
US201313896259 |
申请日期 |
2013.05.16 |
申请人 |
The Scripps Research Institute |
发明人 |
Zhu Saiyong;Ding Sheng |
分类号 |
C12N5/074 |
主分类号 |
C12N5/074 |
代理机构 |
Kilpatrick Townsend & Stockton LLP |
代理人 |
Kilpatrick Townsend & Stockton LLP |
主权项 |
1. A method of inducing a non-pluripotent mammalian cell into an induced pluripotent stem cell, the method comprising:
(a) introducing into the non-pluripotent cell a polynucleotide encoding an Oct4 polypeptide; and (b) contacting the non-pluripotent cell with a small molecule 3′-phosphoinositide-dependent kinase-1 (PDK1) activator, a TGFβ receptor/ALK5 inhibitor, and a MEK inhibitor, thereby inducing the non-pluripotent mammalian cell into an induced pluripotent stem cell. |
地址 |
La Jolla CA US |